July 28th, 2020

Immunovia walks around the world to raise awareness for pancreatic cancer

In the United States, Pancreatic Ductal Adenocarcinoma (PDAC) has surpassed breast cancer as the third deadliest cancer with an increasing mortality rate. PDAC is projected to become the second most deadly cancer by 2030. The high mortality rate is primarily due to the late detection of PDAC and its vague early stage symptoms. Today, >80% of patients […]

November 14th, 2019

Immunovia joins ”Light it purple” initiative on World Pancreatic Cancer Day

November 21, 2019 marks World Pancreatic Cancer Day (WPCD), when all of us around the world should raise awareness of the signs and symptoms of pancreatic cancer, which currently has the lowest survival rate of any cancer. The symptoms of pancreatic cancer can be vague and non-specific. As a result, pancreatic cancer is typically not […]

August 12th, 2019

Immunovia’s pancreatic cancer awareness campaign airs in Times Square, New York City

Immunovia’s new video, highlighting the importance of early detection in pancreatic cancer, will air today in the heart of Times Square in New York City. The campaign will run approximately three times an hour through September 30, 2019 on the “Bowtie Screen” located at the corner of 1500 Broadway and 43rd Ave, on a screen […]

January 11th, 2019

ACS 2018 Cancer Facts & Figures Highlights the Urgent Need for Early Detection Tools and Effective Treatments in Pancreatic Cancer

The American Cancer Society (ACS) recently released updated Cancer Facts & Figures report, providing a snapshot of American cancer statistics and predictions across all cancer sites. In the US, the ACS estimates there will be 56,770 people diagnosed with pancreatic cancer and 45,750 deaths from pancreatic cancer this year. In general, the cancer incidence rate […]

December 20th, 2018

In 2018, Immunovia reached over 24,000 people through 24 Walks in 15 US states

Beginning in April 2018, Immunovia partnered with several prominent patient organizations by sponsoring pancreatic cancer walks across the United States. Organized nationally throughout the year, these walks increase awareness about the disease and raise money for research. The walks also allow people who have lost a loved one to pancreatic cancer to organize a fundraising […]

December 19th, 2018

Nobel Laureates’ visit has special significance for Immunovia

Following the official ceremony in Stockholm, the shared winners of this year’s Nobel Prize in Chemistry, George P. Smith and Sir Gregory P. Winter, visited Medicon Valley to give inspiring presentations on their pioneering work in developing ways of producing human antibodies, the proteins produced by the immune system to help stop intruders from harming the body.  […]

December 18th, 2018

Year End message from Immunovia´s CEO Mats Grahn

As the snow falls over Immunovia’s facilities in Lund, Sweden and Marlborough, USA, season’s greetings from all of us! We’d like to invite all of our investors, collaborators, supporters and suppliers to join in celebrating what has been a year of great progress. Over the last year, we have continued our mission to develop and […]

November 26th, 2018

Allbright Foundation’s green list of Swedish companies promotes Immunovia for gender equality

A recent report published by the Allbright Foundation has shown that the gender balance in Swedish corporations is moving towards more equality, but large differences between companies still exist. Out of the 329 listed companies, 28 have female CEOs, 65% up since last year’s report. Furthermore, equality has advanced more when it comes to these […]

November 22nd, 2018

In a major drive to raise awareness about signs, symptoms and risk factors for pancreatic cancer, over 70 Boston-area primary care clinicians attended Immunovia´s educational symposium at Fenway Park, on World Pancreatic Cancer Day 2018

On November 15, 2018, Immunovia, Inc. sponsored an educational symposium at Fenway Park in honor of World Pancreatic Cancer Day, a day when people across the globe work together to increase awareness of the signs and symptoms of pancreatic cancer. Immunovia’s goal for the day was to increase awareness of the signs, symptoms and risk […]

November 15th, 2018

Immunovia facility expansion

Today, on World Pancreatic Cancer Day November 15 2018, we are delighted to share with you some exciting news about Immunovia. The company is growing and is expanding its facility in Lund, Sweden. In preparation for commercialising IMMray™ PanCan-d for the early detection of pancreatic cancer, Immunovia has completed the expansion of its production and […]

October 12th, 2018

Major Johns Hopkins study calls for new blood biomarker assays to improve pancreatic cancer survival rates in high risk individuals

An important new study by a group of researchers from John Hopkins  recently published in the peer-reviewed journal Gastroenterology has reinforced the importance of surveillance for individuals at high risk due to family history or genetic markers for pancreatic cancer.  In addition, the group called for better biomarker tests for early selection of patients for […]

June 16th, 2017

New Immunovia logotype

Immunovia reveals today the new logotype, one that can continue to grow and adapt with the development of the IMMray™ technology and its clinical applications in cancers and autoimmune diseases. This brand identity change is important for Immunovia for three reasons: -The company name is now easy to read and understand -New IMMray™ based tests […]

February 3rd, 2017

Professor Borrebaeck in Nature Reviews Cancer online magazine

Nature Reviews Cancer magazine published today online, ahead of print an article focused on Precision Diagnostics. This Opinion article, written by Professor Carl Borrebaeck, describes the trends and progress being made in identifying protein biomarker signatures of clinical utility in cancer using, in particular, blood-based proteomics. Click to read article. Pdf for download Title: Precision diagnostics: moving […]

November 4th, 2016

On a mission to advance pancreatic cancer awareness

Pancreatic cancers are one of the most deadly cancers. The cancers are often diagnosed late, making them one of the most hard-to-treat cancers. To create awareness on the aggressive diseases and stir a political discussion for better care, the Medicon Village based company Immunovia is taking the lead on organizing an event at Medicon Village. […]

Welcome to World Pancreatic Cancer Day, Lund Sweden, November 17 2016

Every day, more than 900 people around the world die from pancreatic cancer. Only 6 percent of the patients diagnosed with pancreatic cancer survive 5 years. According to a recent global survey, more than 60 percent of people know “almost nothing” about pancreatic cancer. To create awareness about pancreatic cancer, patient support organizations, industry, healthcare providers and politicians join […]

October 19th, 2016


SAVE THE DATE: November 17, 2016 Every day, more than 900 people around the world die from pancreatic cancer. Only 6 percent of the patients diagnosed with pancreatic cancer survive 5 years. According to a recent global survey, more than 60 percent of people know “almost nothing” about pancreatic cancer. On November 17, 2016, Immunovia […]

June 15th, 2016

IMMray™ PanCan-d poster presentation at the International Symposium on Pancreatic Cancer in Glasgow, UK, June 9-12 2016

The International Symposium on Pancreatic Cancer, “Pancreas 2016”, that took place in Glasgow UK last week, brought together 350 medical oncologists, surgeons, radiographers, gastroenterologists, molecular pathologists, pathologists and clinical and basic scientists from all over the globe, to explore current knowledge in the diagnosis and treatment of pancreatic cancer. Prof. Carl Borrebaeck, Lund University, Sweden, […]


Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports